Drug
Identical-appearing placebo
Identical-appearing placebo is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
2
50%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (50.0%)
N/A2 (50.0%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Sulforaphane to Reduce Symptoms of Schizophrenia
NCT02810964
completednot_applicable
Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
NCT01242371
terminatedphase_2
Statins for the Early Treatment of Sepsis
NCT00528580
completednot_applicable
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
NCT01073202
Clinical Trials (4)
Showing 4 of 4 trials
NCT02810964Phase 2
Sulforaphane to Reduce Symptoms of Schizophrenia
NCT01242371Not Applicable
Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
NCT00528580Phase 2
Statins for the Early Treatment of Sepsis
NCT01073202Not Applicable
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4